标题
Therapeutic novelties in migraine: new drugs, new hope?
作者
关键词
-
出版物
JOURNAL OF HEADACHE AND PAIN
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-18
DOI
10.1186/s10194-019-0974-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted 5-HT1F Therapies for Migraine
- (2018) Marta Vila-Pueyo Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- The Emperor’s New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
- (2018) Peer Tfelt-Hansen et al. HEADACHE
- Early onset of efficacy with erenumab in patients with episodic and chronic migraine
- (2018) Todd Schwedt et al. JOURNAL OF HEADACHE AND PAIN
- Lasmiditan is an effective acute treatment for migraine
- (2018) Bernice Kuca et al. NEUROLOGY
- Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
- (2018) Jessica C Oswald et al. Journal of Pain Research
- Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
- (2017) Joshua M. Cohen et al. HEADACHE
- Human models of migraine — short-term pain for long-term gain
- (2017) Messoud Ashina et al. Nature Reviews Neurology
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab
- (2017) Maria Giamberardino et al. Journal of Pain Research
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- TEV-48125 for the preventive treatment of chronic migraine
- (2016) Marcelo E. Bigal et al. NEUROLOGY
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
- (2015) Tony W Ho et al. CEPHALALGIA
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
- (2014) Paul Rizzoli Neuropsychiatric Disease and Treatment
- Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
- (2013) Marcelo E Bigal et al. CEPHALALGIA
- Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
- (2012) Anthony J Harmar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine
- (2012) Guanglin Luo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Publication committees in clinical trials in headache
- (2011) Peer Carsten Tfelt-Hansen et al. CEPHALALGIA
- Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan
- (2010) David L Nelson et al. CEPHALALGIA
- What have we learnt from triggering migraine?
- (2010) Henrik W Schytz et al. CURRENT OPINION IN NEUROLOGY
- PACAP38 induces migraine-like attacks in patients with migraine without aura
- (2008) Henrik Winther Schytz et al. BRAIN
- The vascular theory of migraine—a great story wrecked by the facts
- (2008) Peter J. Goadsby BRAIN
- Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
- (2008) A Rahmann et al. CEPHALALGIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now